TY - JOUR
T1 - Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP/Probenecid model of parkinson's disease
AU - Anandhan, Annadurai
AU - Essa, Musthafa Mohamed
AU - Manivasagam, Thamilarasan
N1 - Funding Information:
Acknowledgments Financial assistance in the form of a major research project from the University Grant Commission, New Delhi, is gratefully acknowledged.
PY - 2013/2
Y1 - 2013/2
N2 - Neuroinflammation and apoptosis in the dopaminergic neurons of substantia nigra play an important role in the pathogenesis of experimental and clinical Parkinson's disease (PD). This study focused on the possible anti-inflammatory and anti-apoptotic effects of theaflavin (TF), a black tea polyphenol against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice. C57BL/6 male mice were treated with 10 doses of MPTP (25 mg/kg, s.c.) and probenecid (250 mg/kg, i.p.) for 3.5 days interval. TF (10 mg/kg) was administered 1 h prior to the administration of MPTP for 35 days of experimental period. MPTP/p treatment upregulates the release of interleukin-1beta, IL-6, tumor necrosis factor-alpha, IL-10, glial fibrillary acidic protein and Bax, and downregulates anti-apoptotic marker Bcl-2. Oral treatment of black tea polyphenol TF significantly attenuates MPTP-induced neuroinflammation as well as apoptosis. Behavioral studies (catalepsy and akinesia) were carried out to confirm these molecular studies. The results demonstrate that TF mediated its neuroprotection against chronic MPTP-induced toxicity through the involvement of multiple molecular events. It was concluded that TF may provide a precious therapeutic strategy for the treatment of progressive neurodegenerative disease such as PD in future.
AB - Neuroinflammation and apoptosis in the dopaminergic neurons of substantia nigra play an important role in the pathogenesis of experimental and clinical Parkinson's disease (PD). This study focused on the possible anti-inflammatory and anti-apoptotic effects of theaflavin (TF), a black tea polyphenol against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice. C57BL/6 male mice were treated with 10 doses of MPTP (25 mg/kg, s.c.) and probenecid (250 mg/kg, i.p.) for 3.5 days interval. TF (10 mg/kg) was administered 1 h prior to the administration of MPTP for 35 days of experimental period. MPTP/p treatment upregulates the release of interleukin-1beta, IL-6, tumor necrosis factor-alpha, IL-10, glial fibrillary acidic protein and Bax, and downregulates anti-apoptotic marker Bcl-2. Oral treatment of black tea polyphenol TF significantly attenuates MPTP-induced neuroinflammation as well as apoptosis. Behavioral studies (catalepsy and akinesia) were carried out to confirm these molecular studies. The results demonstrate that TF mediated its neuroprotection against chronic MPTP-induced toxicity through the involvement of multiple molecular events. It was concluded that TF may provide a precious therapeutic strategy for the treatment of progressive neurodegenerative disease such as PD in future.
KW - Apoptosis
KW - Behavior
KW - MPTP
KW - Neuroinflammation
KW - Parkinson's disease
KW - Theaflavin
UR - http://www.scopus.com/inward/record.url?scp=84878486068&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84878486068&partnerID=8YFLogxK
U2 - 10.1007/s12640-012-9332-9
DO - 10.1007/s12640-012-9332-9
M3 - Article
C2 - 22669749
AN - SCOPUS:84878486068
SN - 1029-8428
VL - 23
SP - 166
EP - 173
JO - Neurotoxicity Research
JF - Neurotoxicity Research
IS - 2
ER -